You are on page 1of 1

Federal Register / Vol. 70, No.

154 / Thursday, August 11, 2005 / Notices 46881

language interpretation or other Dated: August 4, 2005. DEPARTMENT OF HEALTH AND


reasonable accommodations, should Anthony M. Coelho, Jr., HUMAN SERVICES
notify the Contact Person listed below Acting Director, Office of Federal Advisory
in advance of the meeting. Committee Policy. National Institutes of Health
The meeting will be closed to the [FR Doc. 05–15945 Filed 8–10–05; 8:45 am]
public in accordance with the National Institute of Allergy and
BILLING CODE 4140–01–M
provisions set forth in sections Infectious Diseases, Notice of Meeting
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications Pursuant to section 10(a) of the
DEPARTMENT OF HEALTH AND
and/or contract proposals and the Federal Advisory Committee Act, as
HUMAN SERVICES
discussions could disclose confidential amended (5 U.S.C. Appendix 2), notice
trade secrets or commercial property National Institutes of Health is hereby given of a meeting of the AIDS
such as patentable material, and Research Advisory Committee, NIAID.
personal information concerning National Institute of Diabetes and The meeting will be open to the
individuals associated with the grant Digestive and Kidney Diseases Notice public, with attendance limited to space
applications and/or contract proposals, of Closed Meeting available. Individuals who plan to
the disclosure of which would
attend and need special assistance, such
constitute a clearly unwarranted Pursuant to section 10(d) of the as sign language interpretation or other
invasion of personal privacy. Federal Advisory Committee Act, as reasonable accommodations, should
Name of Committee: National Advisory amended (5 U.S.C. Appendix 2), notice notify the Contact Person listed below
Neurological Disorders and Stroke Council. is hereby given of the following
Date: September 15–16, 2005.
in advance of the meeting.
meeting.
Open: September 15, 2005, 10:30 a.m. to 5 Name of Committee: AIDS Research
p.m. The meeting will be closed to the Advisory Committee, NIAID.
Agenda: Report by the Director, NINDS; public in accordance with the Date: September 26, 2005.
Report by the Director, Division of provisions set forth in sections Time: 1 p.m. to 4:30 p.m.
Extramural Research and other 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: Report from the Division Director
administrative and program developments. as amended. The contract proposals and and other program staff.
Place: National Instiutes of Health,
Building 31, 31 Center Drive, C Wing, the discussions could disclose Place: National Institutes of Health,
Conference Room 6, Bethesda, MD 20892. confidential trade secrets or commercial Natcher Building, 45 Center Drive,
property such as patentable material, Conference Room E1/E2, Bethesda, MD
Closed: September 16, 2005, 8 a.m. to 11:30
a.m. and personal information concerning 20892.
Agenda: To review and evaluate grant individuals associated with the contract Contact Person: Rona L. Siskind, Executive
applications. proposals, the disclosure of which Secretary, AIDS Research Advisory
Place: National Institutes of Health, would constitute a clearly unwarranted Committee, Division of AIDS NIAID/NIH,
Building 31, 31 Center Drive, C Wing 6700B Rockledge Drive, Room 4139,
invasion of personal privacy.
Conference Room 6, Bethesda, MD 20892. Bethesda, MD 20892–7601, 301–435–3732.
Contact Person: Robert Finkelstein, PhD, Name of Committee: National Institute of
Associate Director for Extramural Research, Diabetes and Digestive and Kidney Diseases Any interested person may file
National Institute of Neurological Disorders Special Emphasis Panel, Preclinical Animal written comments with the committees
and Stroke, NIH, 6001 Executive Blvd., Suite Studies for Autoimmunity. by forwarding the statement to the
3309, MSC 9531, Bethesda, MD 20892, (301) Date: September 7, 2005. Contact Person listed on this notice. The
496–9248. Time: 12 p.m. to 4 p.m. statement should include the name,
Any interested person may file Agenda: To review and evaluate contract address, telephone number and when
written comments with the committee proposals. applicable, the business or professional
by forwarding the statement to the Place: National Institutes of Health, Two affiliation of the interested person.
Contact Person listed on this notice. The Democracy Plaza, 6707 Democracy
statement should include the name, Boulevard, Bethesda, MD 20892, (Telephone In the interest of security, NIH has
address, telephone number and when Conference Call). instituted stringent procedures for
applicable, the business or professional Contact Person: Maxine A. Lesniak, MPH, entrance into the building by
affiliation of the interested person. Scientific Review Administrator, Review nongovernment employees. Persons
In the interest of security, NIH has Branch, DEA, NIDDK, National Institutes of without a government I.D. will need to
instituted stringent procedures for Health, Room 756, 6707 Democracy show a photo I.D. and sign-in at the
entrance into the buiding by non- Boulevard, Bethesda, MD 20892–5452, (301) security desk upon entering the
government employees. Persons without 594–7792. lesniakm@extra.niddk.nih.gov. building.
a government I.D. will need to show a (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance
photo I.D. and sign-in at the security Program Nos. 93.847, Diabetes, Program Nos. 93.855, Allergy, Immunology,
desk upon entering the building. Endocrinology and Metabolic Research; and Transplantation Research; 93.856,
Information is also available on the 93.848, Digestive Disease and Nutrition Microbiology and Infectious Diseases
Institute’s/Center’s home page: http:// Research; 93.849, Kidney Diseases, Urology Research, National Institutes of Health, HHS)
www.ninds.nih.gov, where an agenda and Hematology Research, National Institutes Dated: August 5, 2005.
and any additional information for the of Health, HHS) Anthony M. Coelho, Jr.,
meeting will be posted when available. Dated: August 5, 2005. Acting Director, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance Anthony M. Coelho, Jr., Committee Policy.
Program Nos. 93.853, Clinical Research Acting Director, Office of Federal Advisory [FR Doc. 05–15947 Filed 8–10–05; 8:45 am]
Related to Neurological Disorders; 93.854,
Committee Policy. BILLING CODE 4140–01–M
Biological Basis Research in the
Neurosciences, National Institutes of Health, [FR Doc. 05–15946 Filed 8–10–05; 8:45 am]
HHS) BILLING CODE 4140–01–M

VerDate jul<14>2003 16:14 Aug 10, 2005 Jkt 205001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\11AUN1.SGM 11AUN1

You might also like